McKesson Corporation  

(Public, NYSE:MCK)   Watch this stock  
Find more results for mck
150.78
+0.84 (0.56%)
Oct 20 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 150.25 - 151.97
52 week 114.53 - 169.29
Open 150.56
Vol / Avg. 1.40M/1.76M
Mkt cap 31.70B
P/E 6.71
Div/yield 0.34/0.90
EPS 22.46
Shares 210.00M
Beta 1.17
Inst. own 89%
Nov 7, 2017
McKesson Corp at Credit Suisse Healthcare Conference - 12:20PM EST - Add to calendar
Oct 26, 2017
Q2 2018 McKesson Corp Earnings Release - 9:30AM EDT - Add to calendar
Oct 26, 2017
Q2 2018 McKesson Corp Earnings Call - 8:00AM EDT - Add to calendar
Sep 12, 2017
McKesson Corp at Morgan Stanley Healthcare Conference - Webcast
Jul 27, 2017
Q1 2018 McKesson Corp Earnings Release
Jul 27, 2017
McKesson Corp Annual Shareholders Meeting (Estimated)
Jul 27, 2017
Q1 2018 McKesson Corp Earnings Call - Webcast
Jul 26, 2017
McKesson Corp Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin 0.71% 2.66%
Operating margin 1.24% 3.58%
EBITD margin - 2.13%
Return on average assets 2.37% 8.98%
Return on average equity 11.00% 51.89%
Employees 78,000 -
CDP Score - D

Address

1 Post St
SAN FRANCISCO, CA 94104-5203
United States - Map
+1-415-9838300 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

Officers and directors

John Harvey Hammergren Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
James A. Beer Chief Financial Officer, Executive Vice President
Age: 56
Bio & Compensation  - Reuters
Kathleen D. McElligott Executive Vice President, Chief Technology Officer, Chief Information Officer
Age: 61
Bio & Compensation  - Reuters
Lori Ann Schechter Executive Vice President, Chief Compliance Officer, General Counsel
Age: 55
Bio & Compensation  - Reuters
Jorge L. Figueredo Executive Vice President - Human Resources
Age: 56
Bio & Compensation  - Reuters
Paul Coleman Julian Executive Vice President, Group President
Age: 61
Bio & Compensation  - Reuters
Bansi Nagji Executive Vice President - Corporate Strategy and Business Development
Age: 52
Bio & Compensation  - Reuters
Edward A. Mueller Lead Independent Director
Age: 70
Bio & Compensation  - Reuters
Andrew D. Bryant Independent Director
Age: 67
Bio & Compensation  - Reuters
N. Anthony Coles Jr., M.D. Independent Director
Age: 57
Bio & Compensation  - Reuters